Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATNX

Athenex (ATNX) Stock Price, News & Analysis

Athenex logo

About Athenex Stock (NASDAQ:ATNX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$1.52
52-Week Range
N/A
Volume
1.88 million shs
Average Volume
194,316 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athenex and its competitors with MarketBeat's FREE daily newsletter.

ATNX Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Athenex (NASDAQ: ATNX)
See More Headlines

ATNX Stock Analysis - Frequently Asked Questions

Athenex, Inc. (NASDAQ:ATNX) released its quarterly earnings data on Thursday, November, 4th. The company reported ($0.33) EPS for the quarter, beating the consensus estimate of ($0.41) by $0.08. The business had revenue of $32.30 million for the quarter, compared to the consensus estimate of $19.40 million. Athenex had a negative net margin of 86.31% and a negative trailing twelve-month return on equity of 727.79%.

Athenex (ATNX) raised $72 million in an initial public offering (IPO) on Wednesday, June 14th 2017. The company issued 6,000,000 shares at $11.00-$13.00 per share. Credit Suisse, Deutsche, Bank Securities and J.P. Morgan served as the underwriters for the IPO and ICBC International was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athenex investors own include TherapeuticsMD (TXMD), Meta Platforms (META), Sorrento Therapeutics (SRNE), NIO (NIO), NVIDIA (NVDA), Tesla (TSLA) and Ford Motor (F).

Company Calendar

Last Earnings
11/04/2021
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATNX
CIK
1300699
Fax
N/A
Employees
652
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($15.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.43 million
Net Margins
-86.31%
Pretax Margin
-95.92%
Return on Equity
-727.79%
Return on Assets
-44.44%

Debt

Debt-to-Equity Ratio
3.08
Current Ratio
1.09
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$102.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,660,000
Free Float
7,866,000
Market Cap
$1.76 million
Optionable
Optionable
Beta
1.36

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:ATNX) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners